GSEA revealed the E2F pathway, G2M pathway, DNA replication and MYC targets were decreased markedly in the MLL-r AML cells after A-485 treatment (Fig. 4B), but these changes were not observed in the MLL wild type cells (Additional file 1: Fig. S5C). The gene discussed is KMT2A; the disease is acute myeloid leukemia.